VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

Redmile Group, LLC's Holding History (CIK: 0001425738)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 740,261 Value ($000) $8,313 Avg Close — Range —
Q1 2025
Shares 1,207,164 Value ($000) $5,517 Avg Close — Range —
Q4 2024
Shares 1,318,164 Value ($000) $7,434 Avg Close — Range —
Q3 2024
Shares 1,383,366 Value ($000) $6,695 Avg Close — Range —
Q2 2024
Shares 1,463,406 Value ($000) $7,141 Avg Close — Range —
Q1 2024
Shares 1,604,515 Value ($000) $21,308 Avg Close — Range —
Q4 2023
Shares 1,718,669 Value ($000) $23,958 Avg Close — Range —
Q3 2023
Shares 809,777 Value ($000) $10,738 Avg Close — Range —
Q2 2023
Shares 1,061,960 Value ($000) $19,912 Avg Close — Range —
Q1 2023
Shares 1,120,679 Value ($000) $16,160 Avg Close — Range —
Q4 2022
Shares 1,221,903 Value ($000) $23,644 Avg Close — Range —
Q3 2022
Shares 1,505,126 Value ($000) $51,701 Avg Close — Range —
Q2 2022
Shares 1,833,547 Value ($000) $28,017 Avg Close — Range —
Q1 2022
Shares 1,835,328 Value ($000) $41,882 Avg Close — Range —
Q4 2021
Shares 1,708,536 Value ($000) $62,994 Avg Close — Range —
Q3 2021
Shares 1,869,030 Value ($000) $87,844 Avg Close — Range —
Q2 2021
Shares 1,936,530 Value ($000) $116,676 Avg Close — Range —